EQL Pharma is a generics- and speciality pharma company, dedicated to providing cost efficient pharmaceuticals for the Nordic markets. This is accomplished with the highest quality standards and streamlined logistic solutions.
EQL Pharma - last day of trading in paid subscribed shares (BTA) on December 5th 2018
The rights issue that was carried out during October and November 2018 has now been registered with the Swedish Companies Registration Office (Sw. Bolagsverket). Last day of trading in EQL Pharma BTA (paid subscribed shares) will be on December 5th,…
- View all press releases